Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using a medium-fill simulation to evaluate the microbial contamination rate for USP medium-risk-level compounding.

Lawrence A Trissel1, Joseph A Gentempo, Roger W Anderson

  • 1Division of Pharmacy, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|February 22, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Physarum polycephalum Genome Reveals Extensive Use of Prokaryotic Two-Component and Metazoan-Type Tyrosine Kinase Signaling.

Genome biology and evolution·2015
Same author

Palonosetron hydrochloride compatiblity and stability with three B-lactam anitbiotic during simulated y-site adminstration.

International journal of pharmaceutical compounding·2013
Same author

Physical and Chemical Stability of Morphine Sulfate 5mg/mL and 50mg/mL Packaged in Plastic Syringes.

International journal of pharmaceutical compounding·2013
Same author

Physical and chemical stability of low and high concentrations of morphine sulfate with clonidine hydrochloride packaged in plastic syringes.

International journal of pharmaceutical compounding·2013
Same author

Physical and chemical stability of low and high concentrations of morphine sulfate with bupivacaine hydrochloride packaged in plastic syringes.

International journal of pharmaceutical compounding·2013
Same author

Physical and Chemical Stability of Hydromorphone Hydrochloride 1.5 and 80 mg/mL Packaged in Plastic Syringes.

International journal of pharmaceutical compounding·2013

The study found a 5.2% microbial contamination rate in complex sterile compounding. Pharmacists had a lower rate (4.4%) than technicians (6.2%), suggesting touch contamination is a key factor.

Area of Science:

  • Pharmaceutical compounding
  • Microbial contamination
  • Sterile preparations

Background:

  • Complex sterile preparations require meticulous aseptic technique.
  • Assessing contamination rates is crucial for patient safety in healthcare settings.
  • United States Pharmacopeia (USP) guidelines define risk levels for compounding.

Purpose of the Study:

  • To estimate the microbial contamination rate in complex, multiple-step, medium-risk-level sterile compounding.
  • To evaluate the aseptic technique of pharmacists and technicians during compounding.
  • To identify potential sources of microbial contamination in sterile preparations.

Main Methods:

  • Compiled results from 539 aseptic technique evaluations conducted in 2002-2003.
  • Simulated compounding of USP medium-risk-level sterile preparations using sterile growth medium.

Related Experiment Videos

  • Incubated compounded preparations for 14 days to detect microbial growth.
  • Main Results:

    • Overall microbial contamination rate was 5.2% (28 out of 539 evaluations).
    • Pharmacists demonstrated a lower contamination rate (4.4%) compared to technicians (6.2%).
    • Inadvertent touch contamination was identified as a probable primary source of microbial growth.

    Conclusions:

    • Aseptic technique evaluations simulating USP medium-risk compounding revealed a 5.2% contamination rate over two years.
    • Differences in contamination rates between pharmacists and technicians highlight the importance of training and technique.
    • Minimizing touch contamination is critical for reducing microbial contamination in sterile compounding environments.